소화관 출혈 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 소화관 부위별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)
Gastrointestinal Bleeding Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By GI Tract Division, By End Users, By Region, and By Competition, 2020-2030F
상품코드:1886395
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 소화관 출혈 치료 시장은 2024년에 5억 6,244만 달러로 평가되며, 2030년까지 CAGR 5.88%로 성장하며, 7억 9,234만 달러에 달할 것으로 예측됩니다. 세계 소화관 출혈 치료 시장은 식도, 위, 소장, 대장, 직장을 포함한 소화관 내에서 발생하는 출혈을 멈추거나 관리하기 위한 의료적 개입에 초점을 맞추었습니다. 여기에는 근본적인 원인에 대한 대처와 합병증 예방도 포함됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
5억 6,244만 달러
시장 규모 : 2030년
7억 9,234만 달러
CAGR : 2025-2030년
5.88%
가장 빠르게 성장하는 부문
상부 소화관
최대 시장
북미
주요 시장 성장 촉진요인
소화기 질환의 유병률 증가가 세계 소화기 출혈 치료제 시장을 크게 견인하고 있습니다. 소화성 궤양, 위염, 대장암과 같은 질병은 본질적으로 출혈의 위험이 있으며, 의료적 개입이 필요합니다.
주요 시장 과제
첨단 진단 및 치료 장비와 시술에 따른 막대한 비용은 세계 소화기 출혈 치료 시장에서 중요한 도전요인으로 작용하고 있습니다. 이러한 재정적 장벽은 특히 예산이 한정된 의료 시스템이나 개발도상국에서 혁신적이고 효과적인 치료법의 보급과 가용성을 제한함으로써 시장 확대를 직접적으로 억제하고 있습니다.
주요 시장 동향
소화기 출혈 관리에서 원격의료 및 원격 모니터링의 확대는 의료 서비스 제공의 중요한 진화를 나타냅니다. 이러한 추세는 기존의 대면 진료를 넘어 지속적인 환자 모니터링과 퇴원 후 관리 강화를 제공합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 소화관 출혈 치료 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품별(폐쇄 디바이스, 내시경용 지혈 디바이스, 기타)
소화관 부위별(상부 소화관, 하부 소화관)
최종사용자별(병원·클리닉, 외래 수술 센터, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 소화관 출혈 치료 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 소화관 출혈 치료 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 소화관 출혈 치료 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 소화관 출혈 치료 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 소화관 출혈 치료 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 소화관 출혈 치료 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Boston Scientific Corporation
Olympus Corporation
CONMED Corporation
Ovesco Endoscopy AG
Erbe Elektromedizin GmbH
Steris Plc
US Medical Innovations, LLC
Pfizer Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Gastrointestinal Bleeding Treatment Market, valued at USD 562.44 Million in 2024, is projected to experience a CAGR of 5.88% to reach USD 792.34 Million by 2030. The Global Gastrointestinal Bleeding Treatment Market focuses on medical interventions designed to halt or manage blood loss originating within the gastrointestinal tract, encompassing the esophagus, stomach, small intestine, large intestine, and rectum, alongside addressing underlying causes and preventing complications.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 562.44 Million
Market Size 2030
USD 792.34 Million
CAGR 2025-2030
5.88%
Fastest Growing Segment
Upper GI Tract
Largest Market
North America
Key Market Drivers
The increasing prevalence of gastrointestinal disorders significantly drives the Global Gastrointestinal Bleeding Treatment Market. Conditions such as peptic ulcers, gastritis, and colorectal cancer inherently carry a risk of bleeding, necessitating medical intervention. As the global burden of these diseases grows, the demand for effective diagnostic and therapeutic solutions for gastrointestinal bleeding escalates.
Key Market Challenges
The substantial cost associated with advanced diagnostic and therapeutic devices and procedures presents a significant challenging factor within the Global Gastrointestinal Bleeding Treatment Market. This financial impediment directly restrains market expansion by limiting the accessibility and widespread adoption of innovative, highly effective interventions, particularly in healthcare systems with constrained budgets and in developing nations. The high initial capital expenditure required for sophisticated endoscopes, specialized hemostatic instruments, and associated processing units often exceeds the financial capacity of numerous healthcare providers, hindering their ability to invest in these critical technologies.
Key Market Trends
The expansion of telehealth and remote monitoring in gastrointestinal bleeding management represents a significant evolution in healthcare delivery. This trend moves beyond traditional in-person visits to offer continuous patient oversight and enhanced post-discharge care. Telehealth platforms facilitate virtual consultations and enable remote patient monitoring through digital health tools, which supports timely interventions and improves patient engagement by providing convenience and accessibility, especially for individuals in remote areas or those facing mobility challenges.
Key Market Players
Boston Scientific Corporation
Olympus Corporation
CONMED Corporation
Ovesco Endoscopy AG
Erbe Elektromedizin GmbH
Steris Plc
US Medical Innovations, LLC
Pfizer Inc.
Report Scope:
In this report, the Global Gastrointestinal Bleeding Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Gastrointestinal Bleeding Treatment Market, By Product:
Closure Devices
Endoscopic Hemostatic Devices
Others
Gastrointestinal Bleeding Treatment Market, By GI Tract Division:
Upper GI Tract
Lower GI Tract
Gastrointestinal Bleeding Treatment Market, By End Users:
Hospital/Clinics
Ambulatory Surgical Centres
Others
Gastrointestinal Bleeding Treatment Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Gastrointestinal Bleeding Treatment Market.
Available Customizations:
Global Gastrointestinal Bleeding Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Gastrointestinal Bleeding Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Closure Devices, Endoscopic Hemostatic Devices, Others)
5.2.2. By GI Tract Division (Upper GI Tract, Lower GI Tract)
5.2.3. By End Users (Hospital/Clinics, Ambulatory Surgical Centres, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Gastrointestinal Bleeding Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By GI Tract Division
6.2.3. By End Users
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Gastrointestinal Bleeding Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By GI Tract Division
6.3.1.2.3. By End Users
6.3.2. Canada Gastrointestinal Bleeding Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By GI Tract Division
6.3.2.2.3. By End Users
6.3.3. Mexico Gastrointestinal Bleeding Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By GI Tract Division
6.3.3.2.3. By End Users
7. Europe Gastrointestinal Bleeding Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By GI Tract Division
7.2.3. By End Users
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gastrointestinal Bleeding Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By GI Tract Division
7.3.1.2.3. By End Users
7.3.2. France Gastrointestinal Bleeding Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By GI Tract Division
7.3.2.2.3. By End Users
7.3.3. United Kingdom Gastrointestinal Bleeding Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By GI Tract Division
7.3.3.2.3. By End Users
7.3.4. Italy Gastrointestinal Bleeding Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By GI Tract Division
7.3.4.2.3. By End Users
7.3.5. Spain Gastrointestinal Bleeding Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By GI Tract Division
7.3.5.2.3. By End Users
8. Asia Pacific Gastrointestinal Bleeding Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By GI Tract Division
8.2.3. By End Users
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Gastrointestinal Bleeding Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By GI Tract Division
8.3.1.2.3. By End Users
8.3.2. India Gastrointestinal Bleeding Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By GI Tract Division
8.3.2.2.3. By End Users
8.3.3. Japan Gastrointestinal Bleeding Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By GI Tract Division
8.3.3.2.3. By End Users
8.3.4. South Korea Gastrointestinal Bleeding Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By GI Tract Division
8.3.4.2.3. By End Users
8.3.5. Australia Gastrointestinal Bleeding Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By GI Tract Division
8.3.5.2.3. By End Users
9. Middle East & Africa Gastrointestinal Bleeding Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By GI Tract Division
9.2.3. By End Users
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gastrointestinal Bleeding Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By GI Tract Division
9.3.1.2.3. By End Users
9.3.2. UAE Gastrointestinal Bleeding Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By GI Tract Division
9.3.2.2.3. By End Users
9.3.3. South Africa Gastrointestinal Bleeding Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By GI Tract Division
9.3.3.2.3. By End Users
10. South America Gastrointestinal Bleeding Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By GI Tract Division
10.2.3. By End Users
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gastrointestinal Bleeding Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By GI Tract Division
10.3.1.2.3. By End Users
10.3.2. Colombia Gastrointestinal Bleeding Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By GI Tract Division
10.3.2.2.3. By End Users
10.3.3. Argentina Gastrointestinal Bleeding Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By GI Tract Division
10.3.3.2.3. By End Users
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Gastrointestinal Bleeding Treatment Market: SWOT Analysis
